Telomir Pharmaceuticals (TELO) Selling, General & Administrative (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Selling, General & Administrative of $1.32 million for Q2 2026, down 73.7% from $5.03 million a year earlier.
Powered by 
Analysis
Telomir Pharmaceuticals (TELO) Selling, General & Administrative (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Telomir Pharmaceuticals was $7.57 million, down 49.2% year-over-year; for FY2025, it came in at $8.1 million, down 15.9% from FY2024.
- Annual Selling, General & Administrative shows a three-year compound annual growth rate of 628.7% (FY2022 to FY2025).
- In prior years, Telomir Pharmaceuticals' Selling, General & Administrative was $9.64 million in FY2024, $600,192 in FY2023 and $20,941 in FY2022.
- Quarterly Selling, General & Administrative has run from a low of $42,603 in Q1 2023 to a high of $5.38 million in Q3 2024 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in three of the last six quarters, with growth averaging 158.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Telomir Pharmaceuticals | 80.47 Mn | 80.47 Mn | - | 1.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.32 Mn |
| Dec 31, 2025 | 838,472.00 |
| Sep 30, 2025 | 386,951.00 |
| Jun 30, 2025 | 5.03 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.64 Mn |
| Sep 30, 2024 | 5.38 Mn |
| Jun 30, 2024 | 879,695.00 |
| Mar 31, 2024 | 741,541.00 |
| Dec 31, 2023 | 395,290.00 |
| Sep 30, 2023 | 102,191.00 |
| Jun 30, 2023 | 60,107.00 |
| Mar 31, 2023 | 42,603.00 |
API Access
Telomir Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TELO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TELO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TELO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();